Filing Details
Pediatrix Medical Group, Inc. (NYSE:MD) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
Filing Details Pediatrix Medical Group, Inc. (NYSE:MD) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market Context…

Pediatrix Medical Group, Inc. (NYSE:MD) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
Pediatrix Medical Group, Inc.'s stock currently trades at $25.88 with a market capitalization of $1.9B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Pediatrix Medical Group, Inc.'s stock.
All SEC filings for Pediatrix Medical Group, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MD Stock Page
Browse all filings on our MD SEC filings page.
Public companies like Pediatrix Medical Group, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NYSE · MD
$26.61
Down: -$0.36 · -1.35%
Live quote updated
Keep reading